You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Cancer
  5. Thyroid cancer

Lenvatinib and sorafenib for treating differentiated thyroid cancer after radioactive iodine

  • Technology appraisal guidance
  • Reference number: TA535
  • Published:  08 August 2018
  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History
Service Unavailable

Service Unavailable


HTTP Error 503. The service is unavailable.

  • Final appraisal determination document (PDF 404 KB)

    Published:
    15 February 2018
  • Committee papers Appraisal Committee meeting presentation slides (PDF 1.57 MB)

    Published:
    15 February 2018
  • Committee papers (PDF 5.37 MB)

    Published:
    15 February 2018

This page was last updated: 15 February 2018

Back to top